Novel Protein Regulating Proteolytic Activity and Cell Invasiveness
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pharmaceutical compositions lack a protein with a regulating action on proteolytic activity, cell invasiveness, and smooth muscle contraction and relaxation, which are crucial for treating and diagnosing various diseases such as perinatal, cancer, and inflammatory conditions.
Innovation Solution
A novel pharmaceutical composition containing a protein with no known protein motif structure, which regulates proteolytic activity, cell invasiveness, and smooth muscle contraction and relaxation, along with a recombinant vector encoding this protein or its splice variants, is developed for the treatment, prevention, and diagnosis of diseases like perinatal diseases, cancer, and inflammatory diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional pharmaceutical compositions are used, then existing protein functions are available, but they lack regulating action on proteolytic activity, cell invasiveness, and smooth muscle contraction
Solution Approach 1:
The patent introduces a novel protein as an intermediary substance that mediates regulation between multiple physiological processes (proteolytic activity, cell invasiveness, smooth muscle contraction). This single protein acts as a multifunctional regulator that coordinates these previously unrelated processes, thereby achieving broad therapeutic effects across different disease types including perinatal diseases, cancer, and inflammatory diseases.
2Loss of information
If proteins with known motif structures are used, then structural characterization is established, but they cannot regulate proteolytic activity of other proteases
Solution Approach 1:
Instead of searching for regulatory proteins within known motif structures, the patent inverts the approach by identifying a protein with no known motif structure that possesses regulatory functions. This inversion led to the discovery of a completely novel protein family with unique structural characteristics that enable regulatory actions on proteolytic activity, cell invasiveness, and smooth muscle contraction that were previously unrecognized.
3Object-generated harmful factors
If existing proteases are used, then proteolytic activity is provided, but regulating action on other proteases is absent
Solution Approach 1:
The patent describes a protein that performs multiple functions simultaneously: it exhibits proteolytic activity itself while also regulating the activity of other proteases, controls cell invasiveness, and modulates smooth muscle contraction. This multi-functionality allows a single protein to address multiple pathological processes involved in disease development and progression.
Data Source
AI summary
The present invention is intended to provide a specific antibody to a protein that does not have a known protein motif structure but has proteolytic activity and regulating action on the activity of other proteases, cell invasiveness and smooth muscle contraction and relaxation, and is capable of treating, preventing and diagnosing various diseases. The protein is for the treatment, prevention or diagnosis of a disease selected from the group consisting of perinatal diseases, infertility, cancer, nervous system diseases, inflammatory diseases, immune diseases, cardiovascular diseases, endocrine diseases, viral infections, bacterial infections and prion diseases, and is shown in Sequence listing 1.


